09 October 2025
: Case report 
Successful Management of Refractory Pulmonary Mucormycosis Using Intracavitary Amphotericin B: A Case Report and Literature Review
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Educational Purpose (only if useful for a systematic review or synthesis)
Yujie Gao ADEF 1,2, Hansheng Wang
CEF 1,2, Xiao feng Bai C 2, Yi Wu B 2, Xiaobing Li E 2, Meifang Wang CE 1,2, Fahim kanani E 1,2*
DOI: 10.12659/AJCR.949413
Am J Case Rep 2025; 26:e949413
Figure 2 Electron bronchoscopy. (A) On 14 June, pre-treatment electron bronchoscopy suggests purulent inflammation of the left upper lobe of the bronchus. (B) On 26 June, a follow-up electron bronchoscopy after anti-infective treatment suggested chronic inflammatory changes in the bronchus. (C) CT-guided percutaneous pulmonary puncture for intracavitary injection of amphotericin B. (D) Chest CT on 26 September 2024 suggested complete resolution of the inflammation in the lungs.